Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime/VNRX-5133 vs meropenem in complicated urinary tract infection
CTR20191782Phase 3Completed
- Sponsor
- VenatoRx Pharmaceuticals, Inc.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of taniborbactam in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by VenatoRx Pharmaceuticals, Inc.. Started Sep 2019; status: completed.
02
Drugs
taniborbactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20191782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191782.